Axicabtagene ciloleucel compared to tisagenlecleucel for the treatment of aggressive B-cell lymphomaMi Kwon, Pere Barba, Valentín Ortiz‐Maldonado et al.|Haematologica|2022Cited by 131
Ruxolitinib in refractory acute and chronic graft-versus-host disease: a multicenter survey studyJosè Antonio Pérez-Simón, Virginia Escamilla Gómez, Valentín García‐Gutiérrez et al.|Bone Marrow Transplantation|2019Cited by 90
Allogeneic Stem Cell Transplantation As Consolidation Therapy in Patients with Relapsed-Refractory B-Cell Lymphoma Exposed to Bispecific Antibodies: A Study on Behalf of Grupo Español De Transplante y Terapia Celular (GETH-TC)Marta Peña, Alberto Mussetti, Giulia Losi et al.|Blood|2024Cited by 2